TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: The systems biology approach was also recently used to powerful effect in CML, where Abraham, Hopcroft, and colleagues used network analysis of proteomic and transcriptomic data to identify p53 and c-Myc as key hubs that mediate networks to maintain LSCs in CML [9].